Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial
Condition: Left Ventricular Thrombus Interventions: Drug: Warfarin; Drug: Rivaroxaban 20 MG Oral Tablet; Drug: Apixaban 5mg or 2.5mg oral tablet Sponsors: Peshawar Institute of Cardiology; Getz Pharma Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Clinical Trials | Coumadin | Heart | Pharmaceuticals | Research | Thrombosis | Warfarin